Goteborg, Sweden

Per A Carlsson


Average Co-Inventor Count = 7.4

ph-index = 8

Forward Citations = 195(Granted Patents)


Location History:

  • 50 19 Gothenburg, SE (1988)
  • 19 Goteborg, SE (1990 - 1995)
  • Goteborg, SE (1980 - 1997)
  • Gothenburg, SE (1986 - 1998)

Company Filing History:


Years Active: 1980-1998

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Innovator Per A. Carlsson: Pioneering Advances in CNS Therapeutics

Introduction

Per A. Carlsson is a distinguished inventor based in Goteborg, Sweden, whose innovative contributions to the field of pharmaceutical chemistry have led to the development of 17 patents. His work primarily focuses on enhancing therapeutics for central nervous system (CNS) disorders, underscoring his commitment to improving patient outcomes through scientific research and invention.

Latest Patents

Among his latest inventions, Carlsson has developed compounds detailed in his patents, including the formulation relating to 2-aminoindans as selective dopamine D3 ligands. This innovation encompasses a wide range of complex compounds suitable for treating CNS disorders, particularly as 5-HT1A receptor agonists. The structural complexities of these compounds reveal a deep understanding of medicinal chemistry and a dedication to addressing pressing neurological health challenges.

Career Highlights

Throughout his career, Per A. Carlsson has held significant roles in reputable companies, notably at The Upjohn Company, where he worked collaboratively to push the boundaries of pharmaceutical science. His steadfast dedication to research and development has been pivotal in bringing forward novel therapeutics that address various CNS disorders.

Collaborations

Carlsson's collaborative spirit is evident in his partnerships with esteemed colleagues such as Hakan V. Wikstrom and Bengt R. Andersson. Together, they have worked to refine and advance the applications of their research, contributing to a synergistic approach to invention and innovation within the field.

Conclusion

In conclusion, Per A. Carlsson exemplifies the essence of modern innovation through his extensive patent portfolio and significant contributions to pharmaceutical developments. His work has not only enriched the scientific community but has also provided hope for improved treatment options for individuals affected by neurological conditions. Carlsson's legacy continues to inspire aspiring inventors and researchers striving for excellence in the realm of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…